Skip to content
N4 Pharma Plc icon

N4 Pharma Plc

N4P.LStocksBiotechnologyUnited KingdomLSE_AIMGBP

Price

£0.48

Today

+0.0%

YTD

-9.9%

About

N4 Pharma PLC is a UK-based pharmaceutical company specialising in developing innovative drug delivery solutions. Its primary aim is to improve the efficacy and bioavailability of therapeutic compounds, ultimately benefiting patients globally. The company focuses on the pharmaceutical industry, particularly advanced medicine. Operating within the biotechnology and pharmaceutical sector, N4 Pharma PLC specifically focuses on developing its proprietary Nuvec® nanoparticle platform. This technology aims to enable more effective and safer delivery of therapeutic molecules, including vaccines and gene therapies. Keep up to date on the latest share price by adding N4P.L stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for N4P.L (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-1.44
P/S (TTM)280.09
P/B (TTM)1.81
Market cap$2.27M
Cap tierMicro-cap
Industry avg P/E-6.22

Profitability

Gross marginUnknown
EBIT margin-21671.62%
Net margin-11645.34%
ROE-79.99%
ROA-76.07%

Earnings & Revenue

Revenue (TTM)$5,859.00
Revenue growth (1Y)Unknown
EPS (TTM)-$0.00
Free cash flow-$971,450.00
Total debt$0.00

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.06
EmployeesUnknown
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

N4 Pharma Plc (N4P.L) | Dirk Kuyken